HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Firms Should Use Tailored Exposure Assessments For Infant Products

This article was originally published in The Rose Sheet

Executive Summary

Formulators should take infant skin’s unique properties into consideration as they conduct safety assessments for products aimed at that market, P&G’s Dr. Susan Felter suggests at the Personal Care Products Council’s recent Science Symposium.

You may also be interested in...



CIR Panel Affirms Paraben Safety, Will Investigate Infant Skin Properties

With parabens’ use in infant products coming under scrutiny abroad, the CIR Expert Panel intends to learn more about how infant skin reacts to personal-care products. However, the panel maintains its 2006 “safe as used” assessment for parabens.

CIR To Consider Re-Review Of Parabens Following Europe’s New Guidance

Following Denmark’s decision to ban parabens in children’s cosmetics and the EC Scientific Committee on Consumer Safety’s recently revised opinion for parabens acknowledging a possible risk in diaper products for children under 6 months of age, the Cosmetic Ingredient Review Expert Panel may consider re-reviewing the ingredient group.

J&J To Phase Out Quaternium-15 In Baby Shampoo In Response To Demand

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS018347

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel